gliclazide has been researched along with ascorbic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Selvaag, E | 1 |
| Luo, M; O'Brien, RC | 1 |
| Angulo, J; Nevado, J; Peiró, C; Petidier, R; Rodríguez-Mañas, L; Sánchez-Ferrer, A; Sánchez-Ferrer, CF; Vallejo, S | 1 |
| Mamputu, JC; Renier, G | 1 |
8 other study(ies) available for gliclazide and ascorbic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere.
Topics: Antioxidants; Ascorbic Acid; Carbutamide; Chlorpropamide; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Hemolysis; Humans; Hypoglycemic Agents; Nitrogen; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sulfonamides; Sulfonylurea Compounds; Superoxide Dismutase; Tolazamide; Tolbutamide; Ultraviolet Rays; Vitamin E | 1996 |
The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.
Topics: Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Sulfonylurea Compounds; Tolbutamide | 1997 |
Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels.
Topics: Animals; Ascorbic Acid; Bradykinin; Catalase; Free Radical Scavengers; Gliclazide; Glycated Hemoglobin; Humans; In Vitro Techniques; Indomethacin; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Omentum; Potassium Chloride; Rats; Splanchnic Circulation; Superoxide Dismutase; Thiourea; Vasodilation | 2000 |
Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants.
Topics: Animals; Antioxidants; Ascorbic Acid; Cattle; Cell Adhesion; Cell Division; Cells, Cultured; Endothelium, Vascular; Female; Gliclazide; Glycation End Products, Advanced; Humans; Intercellular Adhesion Molecule-1; Male; Monocytes; NF-kappa B; Protein Kinase C; Retinal Vessels; Signal Transduction; Vascular Endothelial Growth Factor A; Vitamin E | 2004 |